Daily computed tomography measurement of needle applicator displacement during high-dose-rate interstitial brachytherapy for previously untreated uterine cervical cancer

Brachytherapy

Volumn 10, Issue 4, 2011, Pages 318-324

  Mikami, Mari ^a   Yoshida, Ken ^a   Takenaka, Tadashi ^a   Yamazaki, Hideya ^b   Kotsuma, Tadayuki ^a   Yoshida, Mineo ^a   Aramoto, Kazumasa ^a   Yamada, Shigetoshi ^a   Ban, Chiaki ^a   Tanaka, Eiichi ^a   Honda, Kazuya ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

High dose rate interstitial brachytherapy; Needle applicator displacement; Uterine cervical cancer

Indexed keywords

TITANIUM;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GRAVITY; HUMAN; INTERSTITIAL BRACHYTHERAPY; MEASUREMENT; NEEDLE; PRIORITY JOURNAL; RADIATION APPLICATOR; RADIATION DOSE; RADIATION DOSE FRACTIONATION; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEEDLES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 79958841776     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2010.11.006     Document Type: Article

References (26)

1. Nag S., Erickson B., Thomadsen B., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:201-211.
2. Beriwal S., Bhatnagar A., Heron D.E., et al. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy 2006, 5:218-222.
3. Syed A.M., Puthawala A.A., Abdlaziz N.N., et al. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002, 54:67-78.
4. Nag S., Martinez-Monge R., Selman A.E., et al. Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina. Gynecol Oncol 1998, 70:27-32.
5. Gupta A.K., Vicini F.A., Frazier A.J., et al. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Int J Radiat Oncol Biol Phys 1999, 43:1055-1060.
6. Demanes D.J., Rodriguez R.R., Bendre D.D., et al. High dose rate transperineal interstitial brachytherapy for cervical cancer: High pelvic control and low complication rates. Int J Radiat Oncol Biol Phys 1999, 45:105-112.
7. Kuipers T., Hoekstra C.J., van 't Riet A., et al. HDR brachytherapy applied to cervical carcinoma with moderate lateral expansion: Modified principles of treatment. Radiother Oncol 2001, 58:25-30.
8. Recio F.O., Piver M.S., Hempling R.E., et al. Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: Results of a pilot study. Int J Radiat Oncol Biol Phys 1998, 40:411-414.
9. Isohashi F., Yoshioka Y., Koizumi M., et al. High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma. Brachytherapy 2009, 8:234-239.
10. Yoshida K., Nose T., Shiomi H., et al. New ambulatory implant technique of high-dose-rate interstitial brachytherapy for prostate cancer. Radiat Med 2006, 24:595-599.
11. Yoshida K., Yamazaki H., Takenaka T., et al. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Int J Radiat Oncol Biol Phys 2010, 77:765-772.
12. Martinez A.A., Pataki I., Edmondson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2001, 49:61-69.
13. Damore S.J., Syed A.M., Puthawala A.A., et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2000, 46:1205-1211.
14. Hoskin P.J., Bownes P.J., Ostler P., et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol 2003, 68:285-288.
15. Kim Y., Hsu I.C., Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys 2007, 8:1-13.
16. Mullokandov E., Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 2004, 58:1063-1071.
17. Pieters B.R., van der Grient J.N., Blank L.E., et al. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. Radiother Oncol 2006, 80:69-72.
18. Simnor T., Li S., Lowe G., et al. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. Radiother Oncol 2009, 93:253-258.
19. Yoshida K., Yamazaki H., Nose T., et al. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 2010, 9:36-41.
20. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
21. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
22. Yoshida K., Nose T., Koizumi M., et al. The usefulness of metal markers for CTV-based dose prescription in high-dose-rate interstitial brachytherapy. J Jpn Soc Ther Radiol Oncol 2002, 13:253-260.
23. Dimopulos J., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006, 66:83-90.
24. Kirisits C., Lang S., Dimopulos J., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006, 65:624-630.
25. Lindegaard J.C., Tanderup K., NielsenSK, et al. Mai-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:756-764.
26. Jürgenliemk-Schulz I.M., Tersteeg R.J., Roesink J.M., et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol 2009, 93:322-330.